Clinical trial
Interferon Gamma in Treating Patients With Recurrent or Metastatic Melanoma or…
NCT00004016 · University of Rochester, Other · Completed
Key facts
| NCT number | NCT00004016 |
|---|---|
| Title | Interferon Gamma in Treating Patients With Recurrent or Metastatic Melanoma or Other Solid Tumors |
| Official title | Phase I Trial of Immunotherapy With Adenovirus-Interferon- Gamma (TG1041) in Patients With Malignant Melanoma |
| Lead sponsor | University of Rochester, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Melanoma (Skin), Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Biological |
| Interventions | recombinant interferon gamma |
| Start date | Apr 1, 1999 |
| First posted | Apr 15, 2004 |
| Last update posted | Jun 6, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: